脓毒症及脓毒性休克初始低血压患者早期晶体液反应性的预测因素、患病率与结局
该研究为前瞻性多中心观察队列的二次分析,纳入9家医院共3686例符合感染、至少2项全身炎症反应综合征标准及低血压标准的患者。初始液体挑战后2350例(64%)为液体反应性。多因素分析显示心力衰竭、低体温、气体交换异常、初始乳酸≥4.0 mmol/L、免疫受损和凝血功能障碍可预测液体无反应性;高风险(≥3个危险因素)患者无反应风险较低风险(0个危险因素)患者高70%(绝对风险高19%)。液体复苏启动时间超过2小时也预测无反应性(OR 1.96)。无反应患者死亡率高15%。
要点
- 3686例脓毒症低血压患者中2350例(64%)对初始液体挑战有持续血流动力学反应。
- ≥3个危险因素(心衰、低体温、气体交换异常、乳酸≥4.0 mmol/L、免疫受损、凝血障碍)患者无反应风险较低风险患者高70%(绝对风险高19%)。
- 液体复苏启动超过2小时预测无反应性(OR 1.96;CI 1.49-2.58),强于所测试的任何患者因素。
- 液体无反应患者死亡率高15%(CI 10-18%)。
- 初始乳酸≥4.0 mmol/L与液体无反应性独立相关(OR 1.28;CI 1.08-1.52)。
适用人群与场景
- 疑似或确诊感染、至少2项全身炎症反应综合征标准、收缩压<90 mm Hg或较基线下降>40%或平均动脉压<65 mm Hg的低血压脓毒症患者。
- 研究场景为9家三级和社区医院,观察期1.5年。
诊断标准与关键阈值
- 全身炎症反应综合征标准至少2项。
- 低血压定义为收缩压<90 mm Hg、较基线下降>40%或平均动脉压<65 mm Hg。
- 液体反应性定义为液体挑战后无血管加压药调整下维持血压正常。
- 高风险定义为≥3个危险因素(心衰、低体温、气体交换异常、初始乳酸≥4.0 mmol/L、免疫受损、凝血障碍)。
红旗征与不能漏的情况
- 液体复苏启动超过2小时预测液体无反应性(OR 1.96;CI 1.49-2.58)。
- 存在≥3个危险因素(心衰、低体温、气体交换异常、乳酸≥4.0 mmol/L、免疫受损、凝血障碍)提示液体无反应高风险。
研究设计与关键结果
- 研究类型为前瞻性多中心观察连续样本队列的二次分析,纳入3686例患者,9家医院,观察1.5年。
- 2350例(64%)对初始液体挑战有反应,为液体反应性。
- 多因素分析中6个因素显著预测无反应性:心力衰竭(OR 1.43;CI 1.20-1.72)、低体温(OR 1.37;CI 1.10-1.69)、气体交换异常(OR 1.33;CI 1.12-1.57)、初始乳酸≥4.0 mmol/L(OR 1.28;CI 1.08-1.52)、免疫受损(OR 1.23;CI 1.03-1.47)、凝血障碍(OR 1.23;CI 1.03-1.48)。
- 高风险(≥3个危险因素)患者无反应风险较低风险(0个危险因素)患者高70%(CI 48-96%),绝对风险高19%(CI 14-25%)。
- 液体启动超过2小时预测无反应性(OR 1.96;CI 1.49-2.58)。
- 无反应患者死亡率高15%(CI 10-18%)。
证据类型、等级与局限
- 证据类型为前瞻性多中心观察连续样本队列的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对脓毒症低血压患者,初始液体挑战后约三分之二有反应,可通过心衰、低体温、气体交换异常、乳酸≥4.0 mmol/L、免疫受损、凝血障碍等因素识别可能无反应者。
- 液体复苏启动超过2小时与液体无反应性独立相关,提示早期启动液体复苏的重要性。
- 高风险(≥3个危险因素)患者液体无反应风险及死亡率更高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The prevalence of responsiveness to initial fluid challenge among hypotensive sepsis patients is unclear. To avoid fluid overload, and unnecessary treatment, it is important to differentiate these phenotypes. We aimed to 1) determine the proportion of hypotensive sepsis patients sustaining favorable hemodynamic response after initial fluid challenge, 2) determine demographic and clinical risk factors that predicted refractory hypotension, and 3) assess the association between timeliness of fluid resuscitation and refractoriness.
DESIGN: Secondary analysis of a prospective, multisite, observational, consecutive-sample cohort.
SETTING: Nine tertiary and community hospitals over 1.5 years.
PATIENTS: Inclusion criteria 1) suspected or confirmed infection, 2) greater than or equal to two systemic inflammatory response syndrome criteria, 3) systolic blood pressure less than 90 mm Hg, greater than 40% decrease from baseline, or mean arterial pressure less than 65 mm Hg.
MEASUREMENTS AND MAIN RESULTS: Sex, age, heart failure, renal failure, immunocompromise, source of infection, initial lactate, coagulopathy, temperature, altered mentation, altered gas exchange, and acute kidney injury were used to generate a risk score. The primary outcome was sustained normotension after fluid challenge without vasopressor titration. Among 3,686 patients, 2,350 (64%) were fluid responsive. Six candidate risk factors significantly predicted refractoriness in multivariable analysis: heart failure (odds ratio, 1.43; CI, 1.20-1.72), hypothermia (odds ratio, 1.37; 1.10-1.69), altered gas exchange (odds ratio, 1.33; 1.12-1.57), initial lactate greater than or equal to 4.0 mmol/L (odds ratio, 1.28; 1.08-1.52), immunocompromise (odds ratio, 1.23; 1.03-1.47), and coagulopathy (odds ratio, 1.23; 1.03-1.48). High-risk patients (≥ three risk factors) had 70% higher (CI, 48-96%) refractory risk (19% higher absolute risk; CI, 14-25%) versus low-risk (zero risk factors) patients. Initiating fluids in greater than 2 hours also predicted refractoriness (odds ratio, 1.96; CI, 1.49-2.58). Mortality was 15% higher (CI, 10-18%) for refractory patients.
CONCLUSIONS: Two in three hypotensive sepsis patients were responsive to initial fluid resuscitation. Heart failure, hypothermia, immunocompromise, hyperlactemia, and coagulopathy were associated with the refractory phenotype. Fluid resuscitation initiated after the initial 2 hours more strongly predicted refractoriness than any patient factor tested.
参考来源
- Leisman DE, Doerfler ME, Schneider SM, et al. Predictors, Prevalence, and Outcomes of Early Crystalloid Responsiveness Among Initially Hypotensive Patients With Sepsis and Septic Shock. Crit Care Med. 2018. PMID: 29112081. doi:10.1097/CCM.0000000000002834
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。